Company / Free Cash Flow
PROKIDNEY CORP. Free Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$155.9M
FY2024
5-year range
-$155.9M / -$30.6M
FY2020-FY2024
Trend
-25.4%
vs FY2023
Sector context
#132 of 194
Health Care
What the data says
At -$156M, PROKIDNEY CORP.'s free cash flow ranks #132 of 194 in the Health Care sector. Free Cash Flow has declined for 4 consecutive years, from -$31M in FY2020 to -$156M in FY2024.
Based on SEC 10-K filings.
-$156M in FY2024.
Declined from -$79M to -$156M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 194 in Health CareTop 68% of 194This company -$155.9M Sector average $470.6M
▼
-133.1% below sector average
Key checks
Key Insights
- PROKIDNEY CORP.'s free cash flow has declined for 4 consecutive years.
- In FY2024, free cash flow decreased 25.4% year-over-year.
- Ranks #132 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$155.9M | -25.4% |
| FY2023 | -$124.3M | -57.4% |
| FY2022 | -$78.9M | -42.2% |
| FY2021 | -$55.5M | -81.1% |
| FY2020 | -$30.6M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026